Skip to main content
Young Hong, MD, Oncology, Camden, NJ, Cooper University Health Care

YoungKiHongMD,MPH, FACS, FSSO

Oncology • Camden, NJ

Gastrointestinal Cancer, Melanoma

Chief, Division of Surgical Oncology and Hepatobiliary, Director of Clinical Research and Cellular Therapy

Join to view full profile

Dr. Hong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hong's full profile

Already have an account?

  • Office

    Cooper University Hospital
    Three Cooper Plaza, Suite 411
    Camden, NJ 08103
    Phone+1 856-968-7014
    Fax+1 856-968-7015
  • Is this information wrong?

Summary

  • Dr. Young Hong is a dual board-certified general surgeon and surgical oncologist/hepatopancreatobiliary surgeon in Camden, NJ. It is affiliated with Cooper University Hospital and MD Anderson Cancer Center at Cooper. He received his medical degree from Virginia Commonwealth University School of Medicine and completed his general surgery residency at MedStar Georgetown University Hospital. He has completed three fellowships, including the Clinical Immunotherapy and Surgical Oncology Fellowship at the National Cancer Institute/National Institutes of Health and the combined Surgical Oncology and Hepatopancreatobiliary fellowship at the University of Louisville. He holds a Master of Public Health in Health Policy from the University of Louisville School of Public Health. He specializes in hepatobiliary surgery, melanoma, pancreas, and surgical oncology (other than breast) and is experienced in tumor immunotherapy, health policy, hepatopancreatobiliary surgery, hyperthermic intraperitoneal chemotherapy, and healthcare disparities. Dr. Hong is the site Principal Investigator of Adoptive Cellular Therapy for metastatic melanoma, head and neck, and non-small cell lung carcinoma. He has a basic science lab focused on epigenetic modulation of immunotherapy on pancreatic adenocarcinoma and hepatocellular carcinoma. He is the Assistant Director of Surgical Research for the surgical residency and Director of Surgical Outcomes Research Group at Cooper University Hospital. He is on the Research Committee of the Society of Surgical Oncology, Society for Surgery of Alimentary Tract, and Americas-Hepato-Pancreato-Biliary Association. He is on the editorial board of Annals of Surgical Oncology and is well-published in his field.

    • Clinical trial treats patients with advanced melanoma

    Dr. Young Ki Hong from MD Anderson Cancer Center and patient Debra Marsdale join Good Day Philadelphia to discuss a breakthrough treatment

    Cooper offers a world-first test of newly approved melanoma therapy to be made i

    A South Jersey woman was the first in the world to receive the therapy as her first treatment for advanced melanoma. The therapy eventually will be made in Phil

    MD Anderson Cooper - Phase 3 Randomized Trial Utilizing TIL Therapy

    MD Anderson at Cooper first to enroll patients in Phase 3 Randomized Clinical Trial Utilizing TIL Therapy plus Pembrolizumab versus Pembrolizumab alone

    TIL Therapy

    In recent years, significant strides have been made in the field of cancer treatment. One such breakthrough is tumor-infiltrating lymphocyte therapy, also known

    Young Ki Hong, MD: Helping Patients Fight Cancer Head On

Education & Training

  • University of Louisville School of Medicine
    University of Louisville School of MedicineFellowship, Complex General Surgical Oncology, 2016 - 2018
  • University of Louisville School of Medicine
    University of Louisville School of MedicineFellowship, Hepatopancreatobiliary Surgery, 2016 - 2018
  • University of Louisville
    University of LouisvilleMPH, Health Policy, 2016 - 2018
  • MedStar Health/Georgetown-Washington Hospital
    MedStar Health/Georgetown-Washington HospitalResidency, Surgery, 2013 - 2016
  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of HealthFellowship, Complex General Surgical Oncology, 2011 - 2013
  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of HealthFellowship, Clinical Immunotherapy, 2010 - 2011
  • Atlantic Health (Morristown)
    Atlantic Health (Morristown)Residency, Surgery, 2008 - 2010
  • Virginia Commonwealth University School of Medicine
    Virginia Commonwealth University School of MedicineClass of 2008
  • University of Virginia
    University of VirginiaB.A., Double Major: Biology & Economics, 1999 - 2003

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2018 - 2025
  • KY State Medical License
    KY State Medical License 2016 - 2019
  • VA State Medical License
    VA State Medical License 2012 - 2018
  • DC State Medical License
    DC State Medical License 2013 - 2016
  • MD State Medical License
    MD State Medical License 2010 - 2014
  • American Board of Surgery Surgery
  • American Board of Surgery Complex General Surgical Oncology

Awards, Honors, & Recognition

  • Resident Manuscript Competition (Dr. Rebecca Platoff) - Epigenetic Dysregulation Correlates with Oncotype Dx Score: Activation of Immune Pathways as a Novel Implication for Adjuvant Therapy in Breast New Jersey Chapter of American College of Surgeons, 2023
  • Rudolph Camishion Surgical Society 31st Annual Resident Research Day - 1st Place Basic Science (Dr. Rebecca Platoff) Cooper University Hospital, 2023
  • Rudolph Camishion Surgical Society 31st Annual Resident Research Day - 1st Place Clinical Science (Dr. Keshav Kooragayala) Cooper University Hospital, 2023
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Personalizing Locoregional Therapy for Patients with Metastatic Colorectal Cancer  
    Hong Y, Martin R, II, Curr Colorectal Cancer Rep
  • Blockchain and non-fungible tokens (NFTs) in surgery: hype or hope?  
    Batchu S, Henry OS, Patel K, Hakim A, Atabek U, Spitz F, Hong Y, Surgery in Practice and Science

Books/Book Chapters

  • Decker Medical Case-based Reviews in Surgical Oncology 
    Chapter: Gastric Cancers. 
    Hong Y, Philips PEditors: Hochwald S..
  • Maingot's Abdominal Operations 
    Chapter: Gastric Adenocarcinoma and other neoplasms 
    Waddah B. Al-Refaie, Young K. Hong, Jennifer F. TsengEditors: Zinner & Ashley.Edition 13th,
  • Operative Thoracic Surgery 
    Chapter: Video Assisted Thorascopic Sympathectomy. 
    Hong Y, Marshall BEditors: Kaiser LR, Jamieson GG, Thompson SS.CRC Press, Boca RatonEdition 6th,2017
  • Join now to see all

Abstracts/Posters

  • TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs. pembro alone in treatment-naive u...
    Young Hong, Daniel Olson, James Larkin, Sajeve Thomas, Juan Martin-Liberal, Andrew Furness, Patrick Terheyden, Gino In, Andrew Poklepovic, Yazan Samhouri, Philip Lamme..., Society for Melanoma Research (SMR), Philadelphia, PA, 11/6/2023
  • Trial in Progress: A Phase 3 study (TILVANCE-301) to assess the efficacy and safety of lifileucel, an autologous tumor-infiltrating lymphocyte cell therapy, in combina...
    James Larkin, Young Hong, Sajeve Thomas, Juan Martin-Liberal, Andrew Furness, Patrick Terheyden, Friedrich Finckenstein, Xiao Wu, Giri Sulur, Wen Shi, Daniel Olson., American Society of Clinical Oncology (ASCO), Chicago, IL, 6/2/2023
  • Novel Epigenetic Therapy For Hyperthermal Intraperitoneal Chemotherapy Enables Gene Remodeling of the Tumor Microenvironment
    Coburn-Flynn O, Butchy M, Calendo G, Emery R, Vercchio V, Knapp K, Ladd Z, Spitz F, Zhang P, Jelinek J, Hong Y, Society for Surgery of Alimentary Tract, Chicago, IL, 5/7/2023
  • Join now to see all

Lectures

  • HIPEC Program at Cooper 
    Dept. of Anesthesiology Grand Rounds, Cooper University Hospital - 11/21/2023
  • Immunotherapy: Success, Challenges, and Novel Strategies 
    Coriell Institute for Medical Research - 9/24/2019
  • Immunotherapy: Success, Challenges, and Novel Strategies 
    Dept. of Surgery Grand Rounds, Cooper University Hospital - 1/15/2019
  • Join now to see all

Press Mentions

  • Advanced melanoma treatment Amtagvi tested at MD Anderson at Cooper
    Advanced melanoma treatment Amtagvi tested at MD Anderson at CooperFebruary 25th, 2024
  • CBS News Philadelphia
    CBS News PhiladelphiaFebruary 15th, 2024
  • Postoperative Opioid Use is Associated with Increased Rates of Grade B/C Pancreatic Fistula After Distal Pancreatectomy
    Postoperative Opioid Use is Associated with Increased Rates of Grade B/C Pancreatic Fistula After Distal PancreatectomyJanuary 12th, 2024
  • Join now to see all

Grant Support

  • Cooper Foundation GrantCooper Foundation/MD Anderson Cooper2018–2024

Committees

  • Complex General Surgical Oncology EPA Workgroup, American Board of Surgery 2024 - Present
  • Chair - Elect, Education Committee of Young Fellows Association of ACS Executive Governing Council 2023 - Present
  • Twitter Subcommittee, Society for Surgery of Alimentary Tract 2023 - Present
  • Social Media Committee, Annals of Surgical Oncology 2022 - Present
  • Admissions Operations Subcommittee, Cooper Medical School of Rowan University 2022 - Present
  • Governing Council Member, Young Fellows Association of American College of Surgeons 2022 - Present
  • Immune Effector Cell (IEC) Standards Subcommittee, The Foundation for the Accreditation of Cellular Therapy 2022 - Present
  • Research Committee Member, Society of Surgical Oncology 2021 - Present
  • Editorial Board, Annals of Surgical Oncology 2021 - Present
  • Research Committee Member, The Society of Surgery for Alimentary Tract 2021 - Present
  • Research Committee Member, Cooper Medical School of Rowan University 2021 - Present
  • Committee Member, MD Anderson Cancer Center Cooper Cancer Committee 2021 - Present
  • Research Committee Member, Americas-Hepato-Pancreato-Biliary Association 2021 - Present
  • 3+4 Dual Degree Medical School Admissions Subcommittee (Guaranteed Medical School Program), Cooper Medical School of Rowan University 2021 - Present
  • Early Career Surgeons Working Group, Society For Surgery Of The Alimentary Tract 2021 - Present
  • Admissions Committee Member, Cooper Medical School Dual Degree Program Sub-Commitee 2020 - Present
  • Member, Association of Academic Surgery Publications Committee 2020 - Present
  • Member, Cooper Surgical Residency Social Media Committee 2020 - Present
  • Admissions Committee Member, Cooper Medical School of Rowan University 2019 - Present
  • Director, Cooper Surgical Outcomes Research Committee 2019 - Present
  • Department of Surgery Representative, Cooper University Hospital Interdepartmental Research Networking Committee 2019 - Present
  • Member, Cooper IACUC Committee 2019 - Present
  • Faculty Sponsor, Cooper Medical School Surgery Interest Group 2019 - Present
  • Resident and Fellow Education Committee, The Society for Surgery of the Alimentary Tract 2018 - Present
  • Program committee, Americas Hepato-Pancreato-Biliary Association 2017 - 2018
  • Resident Member, Medstar Surgical Outcomes Research Center 2014 - 2016
  • Resident Member, Medstar Lombardi Cancer Center Committee on Cancer 2014 - 2015

Research History

  • Director of Cellular TherapyPrincipal Investigator and Director of Autologous Tumor Infiltrating Lymphocytes (TIL) Therapy for Metastatic Melanoma, Non-Small Cell Lung Cancer, and Head & Neck2023 - Present
  • Director of Clinical Research2023 - Present
  • Principal InvestigatorHuman-to-Mouse Cancer Tumor Grafts for Personalized Cancer Medicine2023 - Present
  • Director, Surgical Outcomes Research GroupWeekly surgical outcomes group with fellow medical students, residents, faculty surgeons and collaborators to focus on surgical outcomes projects. Serve as a research mentor for medical students and residents with various projects.2018 - Present
  • Principal InvestigatorOur lab focuses on immunomodulation in hepatopancreatobiliary malignancies by elucidating epigenetic dysregulation.2018 - Present
  • Surgical Oncology Research FellowInvestigating the augmentation of immunotherapy for pancreatic and hepatocellular carcinoma via epigenetic modulation in the laboratory of Dr. Robert C.G. Martin II2016 - 2018
  • MedStar Georgetown Surgical Outcomes ResearchStudied disparities in readmissions of vulnerable hospitals after cancer surgery and unintended consequences of HRRP penalty system of the Affordable Care Act.2014 - 2016
  • Research FellowResearch fellow in laboratory of Dr. David Schrump studying epigenetic regulation of various thoracic malignancies utilizing in vitro, in vivo models, immunoblots, qRT-PCR, and MTT assays.2011 - 2013
  • Research AssistantWorked as research assistant in radiation oncology department laboratory of Dr. Paul Dent using various sensitizing agents to radiation on various melanoma, glioblastoma multiforme, and prostate cell lines.2002 - 2007

Professional Memberships

Other Languages

  • Korean

Hospital Affiliations

Industry Relationships

  • Consultant, Dilon2024 - Present
  • Consultant, Castle Biosciences2024 - Present
  • Consultant, Johnson and Johnson2024 - Present
  • Advisory Panel, Castle BiosciencesAdvisory Panel2022 - Present
  • Consultant, Iovance BiotherapeuticsConsultantDisclosure: Consultant2022 - Present

External Links

Dr. Young Hong, Dr. Young Hong, MD, Dr. Y Hong, Dr. Young Ki Hong